An AI revolution in drugmaking is under way
PATRICK SCHWAB is not your normal pharmaceutical researcher and his workplace is not your normal pharmaceutical laboratory. It has neither benches nor bubbling liquids. White lab coats are absent, too. Instead, Dr Schwab is dressed entirely in black. But that is fitting attire for one whose workplace is in King’s Cross, an area that was once railway yards and industrial buildings but has now, after a makeover, become one of London’s most achingly trendy districts.
Already have an account?Log in
Continue with a free trial
Get full access to our independent journalism for free
Or create a free account to unlock just this article
readers loved this